Morley John E
Divisions of Geriatric Medicine and Endocrinology, Saint Louis University School of Medicine, 1402 S. Grand Blvd., M238, St. Louis, MO, 63104, USA,
Drugs Aging. 2014 May;31(5):331-7. doi: 10.1007/s40266-014-0171-7.
Evidence for treatment of hypertension in older people is limited to placebo-controlled studies that reduced blood pressure in persons over 60 years who had systolic blood pressure >160 mmHg. Generally, physicians measure blood pressure poorly, failing to look for white coat or masked hypertension, orthostasis, postprandial hypotension, or pseudohypertension. There is evidence that if 24-hour ambulatory blood pressures were obtained, the treatment goal should be substantially lower. Sleep apnea, pain, nocturnal hypoglycemia, drugs, excess aldosterone production, and pheochromocytoma should all be considered as causes of hypertension in older persons. Evidence supports a low-dose diuretic or an angiotensin converting enzyme inhibitor as appropriate first-line therapies in older persons.
针对老年人高血压治疗的证据仅限于安慰剂对照研究,这些研究降低了收缩压>160 mmHg的60岁以上人群的血压。一般来说,医生测量血压的水平较差,未能发现白大衣高血压或隐匿性高血压、直立性低血压、餐后低血压或假性高血压。有证据表明,如果测量24小时动态血压,治疗目标应大幅降低。睡眠呼吸暂停、疼痛、夜间低血糖、药物、醛固酮分泌过多和嗜铬细胞瘤都应被视为老年人高血压的病因。有证据支持低剂量利尿剂或血管紧张素转换酶抑制剂作为老年人合适的一线治疗方法。